Transportation Assistance Program for Liver Transplant

NCT05080595 | Completed

• 1 other identifier: HS-21-00576
• Study Type: interventional
• Target: 261
• Locations: 1 country
• Sites: 1

Brief Summary

We propose a rideshare-supported intervention that leverages a partnership with Lyft Health, a HIPAA-secured logistics solution that enables us to provide reliable and efficient transportation for patients. Lyft rides will be provided to patients for any transplant-related medical visits, including but not limited to clinic visits with transplant providers, laboratory testing, and imaging/procedural testing that need to be performed as part of the routine evaluation process and prior to waitlisting for transplant.

Conditions

Liver Transplantation

Keywords

transportation; health services; intervention trial

Outcome Measures

Primary Outcomes (1)

• Time to waitlisting for liver transplant

  The primary outcome will be time to waitlisting for liver transplant, defined as time (in days) from initial evaluation visit date to date of official listing for liver transplant in the United Network for Organ Sharing database.

  through study completion, an average of 1 year

Secondary Outcomes (8)

• Proportion with reported transportation barriers

  1 year

• Proportion waitlisted/transplanted

  through study completion, an average of 1 year

• Number of no-shows/cancellations

  through study completion, an average of 1 year

• Number of hospitalizations

  through study completion, an average of 1 year

• Time to transplant

  through study completion, an average of 1 year

Study Arms (3)

Transportation assistance, reports unreliable transportation

EXPERIMENTAL

Lyft rides provided to transplant-related appointments

Other: Transportation assistance (Lyft rides)

No transportation assistance, reports unreliable transportation

NO INTERVENTION

No intervention, standard-of-care

Transportation assistance, control

NO INTERVENTION

No intervention, standard-of-care

Interventions

Transportation assistance (Lyft rides) OTHER

Lyft rides will be provided to patients for any transplant-related medical visits

Transportation assistance, reports unreliable transportation

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults (18+)
• Attended Phase 1 or Phase 1/2 Liver Transplant clinic visit

You may not qualify if:

• Unable to provide informed consent
• Pregnant women or prisoners
• Deemed ineligible for liver transplantation during initial evaluation visit
• Not referred for Phase 2 visit at the time of Phase 1 visit among those with initial Phase 1 visit only
• Hospitalized at the time of initial Phase 1 or Phase1/2 visit
• No access to handheld or landline telephone
• Residence outside of 60 miles from Keck Hospital

Sponsors & Collaborators

• University of Southern California: lead

Study Sites (1)

Keck Transplant Clinic

Los Angeles, California, 90033, United States

Location

Related Publications (1)

• Zhou K, Wong C, Almanza J, Chen A, Kahn J, Ahearn A, Terrault N. A pilot randomized controlled trial of a transportation assistance program in liver transplant (TAP-LT) candidates. Liver Transpl. 2026 Feb 18. doi: 10.1097/LVT.0000000000000832. Online ahead of print.

  PMID: 41705818 DERIVED

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: September 30, 2021
• First Posted: October 18, 2021
• Study Start: January 24, 2022
• Primary Completion: November 27, 2023
• Study Completion: August 2, 2024
• Last Updated: May 4, 2026

Record last verified: 2026-04

Locations

US (1)